Patent · US Active

Formulations for TACI-immunoglobulin fusion proteins

US8637021B2 · kind B2 · utility

3Cited by

1References

21Claims

0Family size

Assignee

ARES TRADING S.A. · CH

Inventors

Alessandra Del Rio · Roma, IT
Gianluca Rinaldi · Monterotondo, IT
Joel Richard

Key dates

Filing date	Nov 12, 2008
Grant date	Jan 28, 2014
Priority date	—
Expiry date	Feb 22, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to formulations of TACI-Immunoglobulin fusion proteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.